First a quick description (Source: Yahoo Finance):
Cumberland Pharmaceuticals Inc. (CPIX), a specialty pharmaceutical company, engages in the acquisition, development and commercialization of branded prescription products for the hospital acute care and gastroenterology markets primarily in the United States. Its principal products include Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. It also develops Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome.
The drugs Cumberland has on the market were responsible for the following distribution of revenues in the ...
Only subscribers can access this article, which is part of the PRO research library covering 3,584 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: